Yujian Zhao - Suzhou Novoprotein Deputy Director
| 688137 Stock | 35.51 0.25 0.71% |
Director
Yujian Zhao is Deputy Director of Suzhou Novoprotein Scientific
| Age | 53 |
| Phone | 86 512 6391 9116 |
| Web | https://www.novoprotein.com.cn |
Suzhou Novoprotein Management Efficiency
The company has return on total asset (ROA) of (0.0221) % which means that it has lost $0.0221 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0254) %, meaning that it generated substantial loss on money invested by shareholders. Suzhou Novoprotein's management efficiency ratios could be used to measure how well Suzhou Novoprotein manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | DIRECTOR Age | ||
| Yu Song | Guangzhou Haige Communications | 49 | |
| Guangqing Li | Shandong Sinoglory Health | 58 | |
| Xiaochun Zhong | Jiangxi Hengda Hi Tech | 55 | |
| Xiaochuang Zhang | Sunwave Communications Co | 42 | |
| Ping Wang | Sunwave Communications Co | 48 | |
| Rong Wang | Tianjin Hi Tech Development | 53 | |
| Feng Tian | Shandong Sinoglory Health | 51 | |
| Shuo Yang | Tianjin Hi Tech Development | N/A | |
| Li Liu | Tianjin Hi Tech Development | N/A | |
| Feng Ren | Sunwave Communications Co | 48 | |
| Enxue Hu | Jiangxi Hengda Hi Tech | 60 | |
| Wei Tan | Guangzhou Haige Communications | 57 | |
| Guangyu Zhu | Jiangxi Hengda Hi Tech | 35 | |
| Tiegang Li | Guangzhou Haige Communications | 48 | |
Management Performance
| Return On Equity | -0.0254 | |||
| Return On Asset | -0.0221 |
Suzhou Novoprotein Leadership Team
Elected by the shareholders, the Suzhou Novoprotein's board of directors comprises two types of representatives: Suzhou Novoprotein inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Suzhou. The board's role is to monitor Suzhou Novoprotein's management team and ensure that shareholders' interests are well served. Suzhou Novoprotein's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Suzhou Novoprotein's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Duqiang Wang, Secretary GM | ||
| Zhang Zheng, Sales Director | ||
| Yingming Wang, Deputy Director | ||
| Yujian Zhao, Deputy Director | ||
| Dongye Zhang, Accounting CFO | ||
| Huaxing Zhu, Chairman Founder |
Suzhou Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Suzhou Novoprotein a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0254 | |||
| Return On Asset | -0.0221 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.50) % | |||
| Current Valuation | 1.89 B | |||
| Shares Outstanding | 70.18 M | |||
| Shares Owned By Insiders | 71.27 % | |||
| Shares Owned By Institutions | 5.01 % | |||
| Price To Book | 1.17 X | |||
| Price To Sales | 19.55 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Suzhou Stock
Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.